F-18 FDG PET

DEVICE2 trials

Sponsors

Proactina S.A., Wake Forest University Health Sciences

Conditions

Dose Response Relationship, DrugGlioma (Diagnosis)

Phase 2

Technical Performance Assessment of Tc-99m Tetrofosmin for Differentiation of Recurrence vs Radiation Necrosis in Patients With Glioma

CompletedNCT02971319

Proactina S.A.Glioma (Diagnosis)

Start: 2016-09-30End: 2017-12-17Updated: 2018-01-26

Unknown Phase

Infiltration Effect on SUV

TerminatedNCT03320564

Wake Forest University Health SciencesDose Response Relationship, Drug

Start: 2018-08-27End: 2019-02-13Updated: 2022-03-18